{"id":"placebo-saline-water","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (if administered parenterally)"},{"rate":null,"effect":"Minimal systemic adverse events expected"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Saline water is a physiologically inert solution containing sodium chloride and water. Any observed clinical benefit in placebo-controlled trials results from psychological and neurobiological responses to the expectation of treatment rather than from direct molecular action. It serves as a control comparator in clinical trials to distinguish true drug efficacy from placebo response.","oneSentence":"Placebo saline water has no active pharmacological mechanism; therapeutic effects arise from the placebo effect and patient expectation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:25.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control/comparator agent in clinical trials (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT04454203","phase":"PHASE4","title":"Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension","status":"RECRUITING","sponsor":"Duke University","startDate":"2021-02-05","conditions":"Tourniquet Hypertension, Intraoperative Hypertension, Total Ankle Arthroplasty","enrollment":40},{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT06426823","phase":"NA","title":"The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2023-11-01","conditions":"Blood Flow","enrollment":10},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT05997264","phase":"PHASE2","title":"Anthrax AV7909 Boost Evaluation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2023-12-05","conditions":"Anthrax","enrollment":220},{"nctId":"NCT06597006","phase":"PHASE3","title":"Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-28","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":9},{"nctId":"NCT06305780","phase":"PHASE2","title":"RECOVER-AUTONOMIC Platform Protocol","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":381},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT03621670","phase":"PHASE3","title":"Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-07-27","conditions":"Infections, Meningococcal","enrollment":1196},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT01073787","phase":"PHASE1, PHASE2","title":"Intravenous Fluid for Pediatric Migraine in the Emergency Department","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2010-07","conditions":"Migraine, Headache","enrollment":46},{"nctId":"NCT07366710","phase":"NA","title":"Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2024-11-05","conditions":"Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease)","enrollment":36},{"nctId":"NCT04607408","phase":"PHASE1","title":"Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2020-11-10","conditions":"HIV Infections","enrollment":38},{"nctId":"NCT06572267","phase":"PHASE2","title":"Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2024-10-16","conditions":"Coronary Artery Disease","enrollment":18},{"nctId":"NCT07053774","phase":"PHASE2","title":"Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-11-05","conditions":"Pain, Acute","enrollment":24},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT05002998","phase":"PHASE4","title":"TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study","status":"COMPLETED","sponsor":"Amgen","startDate":"2021-09-16","conditions":"Thyroid Eye Disease","enrollment":313},{"nctId":"NCT05845398","phase":"PHASE1","title":"Phase 1b Study of DCR-AUD in Healthy Volunteers","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2023-01-29","conditions":"Alcohol Use Disorder","enrollment":16},{"nctId":"NCT04659863","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-02-16","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":13},{"nctId":"NCT04652726","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-01-27","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":141},{"nctId":"NCT06726876","phase":"PHASE3","title":"Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-10-01","conditions":"Periodontitis, Hemodialysis","enrollment":150},{"nctId":"NCT05182125","phase":"PHASE1","title":"Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2021-11-25","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT04902703","phase":"PHASE2","title":"Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-06-01","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT06770491","phase":"PHASE1","title":"A Phase 1 Study of Y-3 in US Healthy Volunteers.","status":"COMPLETED","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2025-02-04","conditions":"Safety, Tolerability, Pharmacokinetic Study in Healthy Volunteers","enrollment":20},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT06785272","phase":"PHASE3","title":"Magnesium Trial in Acute Asthma in Emergency Department","status":"RECRUITING","sponsor":"Suzanne Schuh","startDate":"2025-10-08","conditions":"Asthma","enrollment":192},{"nctId":"NCT06630884","phase":"PHASE1","title":"Inflammatory Challenge and Fear","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-28","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":288},{"nctId":"NCT06542198","phase":"NA","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-09-10","conditions":"Polyuria-polydipsia Syndrome, Arginine Vasopressin Deficiency, Primary Polydipsia","enrollment":42},{"nctId":"NCT03705234","phase":"PHASE3","title":"A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2018-10-30","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":16124},{"nctId":"NCT05850078","phase":"NA","title":"FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)","status":"COMPLETED","sponsor":"Freya Biosciences ApS","startDate":"2023-05-18","conditions":"Vaginal Flora Imbalance","enrollment":97},{"nctId":"NCT03608033","phase":"PHASE3","title":"Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy","status":"TERMINATED","sponsor":"Omeros Corporation","startDate":"2018-04-05","conditions":"IgA Nephropathy","enrollment":360},{"nctId":"NCT07268846","phase":"NA","title":"Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"AC Camargo Cancer Center","startDate":"2025-06-01","conditions":"Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)","enrollment":164},{"nctId":"NCT00636480","phase":"PHASE3","title":"Preoperative Skin Preparation Evaluation","status":"COMPLETED","sponsor":"C. R. Bard","startDate":"2007-10","conditions":"Topical Antisepsis","enrollment":60},{"nctId":"NCT06597019","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-12-09","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":51},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT06628947","phase":"PHASE2","title":"A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa","status":"RECRUITING","sponsor":"Kiora Pharmaceuticals, Inc.","startDate":"2025-08-29","conditions":"Retinitis Pigmentosa","enrollment":36},{"nctId":"NCT06546709","phase":"PHASE1","title":"DMID 23-0015; Lassa Fever CVD 1000","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wilbur Chen, MD, MS","startDate":"2025-01-13","conditions":"Lassa Fever","enrollment":55},{"nctId":"NCT05684692","phase":"PHASE2","title":"Screening Trial for Pain Relief in Schwannomatosis (STARFISH)","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-08-31","conditions":"Schwannomatosis, Schwannomas, Pain, Chronic","enrollment":40},{"nctId":"NCT04347239","phase":"PHASE2","title":"Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19","status":"COMPLETED","sponsor":"CytoDyn, Inc.","startDate":"2020-04-16","conditions":"Coronavirus Disease 2019","enrollment":484},{"nctId":"NCT06216366","phase":"PHASE2","title":"Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioAegis Therapeutics Inc.","startDate":"2025-08-15","conditions":"Decompression Sickness","enrollment":36},{"nctId":"NCT02367040","phase":"PHASE3","title":"Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-03","conditions":"Lymphoma,Non-Hodgkin","enrollment":458},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT06361537","phase":"PHASE3","title":"Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks","status":"RECRUITING","sponsor":"Octapharma","startDate":"2024-04-30","conditions":"Acute Hereditary Angio Edema","enrollment":124},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT05239221","phase":"PHASE1, PHASE2","title":"AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-09-07","conditions":"Chronic Hypoparathyroidism","enrollment":132},{"nctId":"NCT06934473","phase":"NA","title":"Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals","status":"RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-05-21","conditions":"Bloodpressure","enrollment":16},{"nctId":"NCT05868837","phase":"PHASE3","title":"Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2022-02-28","conditions":"Myasthenia Gravis, Generalized","enrollment":40},{"nctId":"NCT06447194","phase":"PHASE1, PHASE2","title":"Effect of RECK in Posterior Spinal Fusion","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2025-10-01","conditions":"Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease, Degenerative Spondylolisthesis","enrollment":""},{"nctId":"NCT06282965","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2024-05-28","conditions":"Traumatic Brain Injury","enrollment":90},{"nctId":"NCT07085637","phase":"NA","title":"IV Hydrogen Nanobubbles for Cardiac Function and QoL","status":"COMPLETED","sponsor":"Indonesia Molecule Institute","startDate":"2022-09-19","conditions":"Cardiovascular Diseases, Hypertension, Blood Pressure","enrollment":52},{"nctId":"NCT04658667","phase":"PHASE1","title":"HIV Vaccine in HIV-uninfected Adults","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2022-02-03","conditions":"HIV","enrollment":81},{"nctId":"NCT06524960","phase":"PHASE1, PHASE2","title":"Denosumab for Type 1 Diabetes","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-09-03","conditions":"Type 1 Diabetes","enrollment":45},{"nctId":"NCT06305793","phase":"PHASE2","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19","enrollment":200},{"nctId":"NCT03384966","phase":"PHASE2","title":"A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2018-01-24","conditions":"Stable Coronary Artery Disease","enrollment":346},{"nctId":"NCT03430661","phase":"PHASE1","title":"A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2018-01-24","conditions":"Healthy","enrollment":77},{"nctId":"NCT03173625","phase":"PHASE1","title":"A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2016-11-29","conditions":"Healthy Subjects","enrollment":72},{"nctId":"NCT05717062","phase":"PHASE2","title":"Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)","status":"COMPLETED","sponsor":"Ophirex, Inc.","startDate":"2023-05-30","conditions":"Snakebite, Envenoming, Snake","enrollment":140},{"nctId":"NCT04129931","phase":"PHASE2","title":"PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-12-19","conditions":"Asthma","enrollment":395},{"nctId":"NCT07025876","phase":"EARLY_PHASE1","title":"PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2023-11-18","conditions":"Streptococcus Pneumoniae Pneumonia","enrollment":240},{"nctId":"NCT06714513","phase":"PHASE1","title":"ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74","status":"RECRUITING","sponsor":"Quratis Inc.","startDate":"2025-05-09","conditions":"Tuberculosis, Pulmonary","enrollment":144},{"nctId":"NCT05160532","phase":"PHASE2","title":"Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-04-10","conditions":"Knee Osteoarthritis","enrollment":48},{"nctId":"NCT06580444","phase":"PHASE2","title":"Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study","status":"NOT_YET_RECRUITING","sponsor":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","startDate":"2025-07-28","conditions":"Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)","enrollment":40},{"nctId":"NCT04898283","phase":"PHASE3","title":"Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.","status":"RECRUITING","sponsor":"Inmunotek S.L.","startDate":"2021-05-31","conditions":"Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic","enrollment":180},{"nctId":"NCT04891237","phase":"PHASE3","title":"Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen","status":"RECRUITING","sponsor":"Inmunotek S.L.","startDate":"2021-06-14","conditions":"Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic","enrollment":180},{"nctId":"NCT04805073","phase":"PHASE4","title":"Treatment of Pruritus With Intramuscular Promethazine","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-08-09","conditions":"Pruritus, Pregnancy Related","enrollment":72},{"nctId":"NCT06930456","phase":"NA","title":"Comparison Between Intravenous Hydrocortisone and Ondansetron in Prevention of Post Spinal Anesthesia Hypotension","status":"ENROLLING_BY_INVITATION","sponsor":"Nada kamel Elgamal","startDate":"2024-03-01","conditions":"Post Spinal Anaesthesia Hypotension","enrollment":120},{"nctId":"NCT03868709","phase":"PHASE4","title":"Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2019-03-12","conditions":"Postoperative Complications, Long-term Outcome","enrollment":864},{"nctId":"NCT06895252","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis (UC)","enrollment":220},{"nctId":"NCT06890650","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohn Disease","enrollment":168},{"nctId":"NCT06906445","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis","enrollment":220},{"nctId":"NCT06859580","phase":"PHASE4","title":"Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-03-01","conditions":"Primary Hyperparathyroidism","enrollment":140},{"nctId":"NCT04857671","phase":"PHASE3","title":"Botulinum Toxin A in Frequent and Chronic Tension-type Headache","status":"COMPLETED","sponsor":"Helse Nord-Trøndelag HF","startDate":"2022-10-03","conditions":"Tension-Type Headache","enrollment":66},{"nctId":"NCT05579639","phase":"PHASE2","title":"Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-04-04","conditions":"Allogeneic Stem Cell Transplantation","enrollment":419},{"nctId":"NCT03982160","phase":"PHASE4","title":"L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients","status":"RECRUITING","sponsor":"The University of Texas at Arlington","startDate":"2018-02-01","conditions":"Chronic Kidney Disease","enrollment":15},{"nctId":"NCT05633446","phase":"PHASE1, PHASE2","title":"Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)","status":"NOT_YET_RECRUITING","sponsor":"Gylden Pharma Ltd","startDate":"2025-09-01","conditions":"Coronavirus, SARS-CoV-2 Infection, COVID-19","enrollment":110},{"nctId":"NCT05359133","phase":"PHASE2","title":"A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain","status":"TERMINATED","sponsor":"Wex Pharmaceuticals Inc.","startDate":"2022-04-19","conditions":"Chemotherapy-induced Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy","enrollment":35},{"nctId":"NCT03682172","phase":"EARLY_PHASE1","title":"Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2018-05-01","conditions":"Effect of Glucagon-like Peptide 2 on Gallbladder Motility","enrollment":15},{"nctId":"NCT06826222","phase":"NA","title":"Sodium Bicarbonate Intake on Endurance Performance","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2024-11-03","conditions":"The Effects of Sodium Bicarbonate Supplementation on Endurance Performance in Recreational Female Runners","enrollment":19},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT06805448","phase":"PHASE1, PHASE2","title":"Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-21","conditions":"Sjorgren's Syndrome","enrollment":40},{"nctId":"NCT05095701","phase":"PHASE4","title":"An Immunity Persistence Study of Live Attenuated Varicella Vaccine","status":"ENROLLING_BY_INVITATION","sponsor":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","startDate":"2021-12-18","conditions":"Varicella","enrollment":703},{"nctId":"NCT05895838","phase":"PHASE3","title":"The Danish Out-of-Hospital Cardiac Arrest Study","status":"RECRUITING","sponsor":"Christian Hassager","startDate":"2023-06-16","conditions":"Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome","enrollment":1000},{"nctId":"NCT04156581","phase":"PHASE4","title":"Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-11-19","conditions":"Opioid Use, Pain, Postoperative","enrollment":46},{"nctId":"NCT05021640","phase":"PHASE1","title":"Study of DCR-AUD in Healthy Volunteers","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2021-09-21","conditions":"Alcohol Use Disorder (AUD)","enrollment":36},{"nctId":"NCT04410042","phase":"PHASE3","title":"Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2021-01-29","conditions":"Cancer of the Bone, Limb Salvage","enrollment":15},{"nctId":"NCT05166811","phase":"PHASE2","title":"Timely Intravenous Magnesium for Asthma in Children","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-09-12","conditions":"Asthma","enrollment":52},{"nctId":"NCT06737549","phase":"PHASE4","title":"Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial","status":"RECRUITING","sponsor":"The Third Affiliated hospital of Zhejiang Chinese Medical University","startDate":"2024-12","conditions":"Ischemic Stroke, Dysphagia","enrollment":144},{"nctId":"NCT06296212","phase":"PHASE3","title":"Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.","status":"RECRUITING","sponsor":"Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica","startDate":"2024-06-25","conditions":"Pneumonia, Myocardial Injury","enrollment":178},{"nctId":"NCT05555758","phase":"PHASE1","title":"Aom0319 SAD Study in Healthy Subjects","status":"COMPLETED","sponsor":"Amckaus PTY LTD.","startDate":"2022-12-15","conditions":"Healthy Volunteers","enrollment":38},{"nctId":"NCT04607668","phase":"PHASE3","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):","status":"TERMINATED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-01-06","conditions":"Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity","enrollment":326},{"nctId":"NCT05788237","phase":"PHASE1","title":"A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-03-09","conditions":"Healthy","enrollment":508},{"nctId":"NCT06692582","phase":"NA","title":"Electrolysed Saline Rinse As an Adjunct for Treatment of Chronic Periodontitis","status":"RECRUITING","sponsor":"University of Ljubljana","startDate":"2024-06-06","conditions":"Periodontitis","enrollment":60},{"nctId":"NCT06678607","phase":"PHASE1","title":"Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older","status":"COMPLETED","sponsor":"Shanghai Reinovax Biologics Co.,LTD","startDate":"2023-11-19","conditions":"Pneumococcal Infectious Disease","enrollment":240},{"nctId":"NCT03355053","phase":"PHASE2","title":"Investigation of Sleep in the Intensive Care Unit","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-05-29","conditions":"Delirium, Sleep","enrollment":522},{"nctId":"NCT04547842","phase":"EARLY_PHASE1","title":"Mirtazapine Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-09-01","conditions":"Post Operative Nausea and Vomiting","enrollment":90},{"nctId":"NCT06618716","phase":"NA","title":"Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital, Linkoeping","startDate":"2024-09-05","conditions":"Inflammation Biomarkers, Inflammation","enrollment":25},{"nctId":"NCT05484154","phase":"PHASE3","title":"Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke","status":"WITHDRAWN","sponsor":"ZZ Biotech, LLC","startDate":"2024-10","conditions":"Ischemic Stroke","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NaCl water"],"phase":"marketed","status":"active","brandName":"Placebo (saline water)","genericName":"Placebo (saline water)","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Placebo saline water has no active pharmacological mechanism; therapeutic effects arise from the placebo effect and patient expectation. Used for Control/comparator agent in clinical trials (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}